Aberrant histone acetylation due to the imbalance activity of HATs and HDAC activity within the tumour cells may cause the transcriptional repression of tumour suppressor genes and impair the activation of antitumour immunity, promote immune escape and drug resistance, and ultimately contribute to tumour development and progression [58]. The gene discussed is HDAC9; the disease is neoplasm.